Locations
Company type
Result types
Industries
Employees
Founding year
The B2B platform for the best purchasing descision. Identify and compare relevant B2B manufacturers, suppliers and retailers
Close
Filter
Result configuration
Continents
Select continent
Locations
Result types
Company type
Select company type
Industries
Select industry
Company status
Select company status preset
Number of employees
Min.
Max.
Founding year
OrphanDC: We're all about connecting Patients to Orphan Drugs Novel Therapies and Clinical Trials
São Paulo, Brazil
C
11-50 Employees
2016
Key takeaway
The company focuses on providing clinical trial treatments and access for patients with rare and complex conditions in Latin America, which may include innovative therapies like CAR-T cell therapy.
Reference
Service
OrphanDC | Services
River City Biotecnologia
Luziânia, Brazil
C
11-50 Employees
2014
Key takeaway
River City Biotecnologia Brazil is a key player in the cell culture industry, which is essential for the development of therapies like CAR-T cell therapy. Their commitment to maintaining detailed records of traceability for serum batches underscores their dedication to quality and compliance in biotechnological processes.
Reference
Core business
Home | River City Biotecnologia
OTAWA Health
São Paulo, Brazil
C
1-10 Employees
2019
Key takeaway
OTAWA Health is revolutionizing oncology care with its Advanced Digital Oncology platform, which enhances the management and treatment of cancer through innovative solutions and structured Real-World Data. This approach aims to improve outcomes for patients with cancer by providing tools for better care coordination and decision-making.
Reference
Core business
Otawa Health – A DIGITAL ONCOLOGY platform made of a specialized oncology-EHR/CDS solution created BY and FOR cancer care professionals. OTAWA Health contributes to better management of cancer centers enabling a comprehensive and coordinated care while collecting structured oncology Real-World Data for Real-World Evidence studies to improve outcomes for patients with cancer.
Looking for more accurate results?
Find the right companies for free by entering your custom query!
25M+ companies
250M+ products
Free to use
CarrierWeb
Rio de Janeiro, Brazil
C
51-100 Employees
2002
Key takeaway
CarrierWeb, now part of PowerFleet, is involved in innovative healthcare solutions.
Reference
Core business
CarrierWeb USA
Medison Pharma
Israelândia, Brazil
C
- Employees
1996
Key takeaway
Medison is a global pharmaceutical company dedicated to providing access to highly innovative therapies, emphasizing their mission to save lives by bridging market access gaps. They actively seek and facilitate faster access to breakthrough treatments for patients in international markets.
Reference
Core business
Medison Pharma - Always Ahead - Medison
Medison is a global pharma company focused on providing access to highly innovative therapies in international markets
Raggi-X
São Paulo, Brazil
C
1001-5000 Employees
2007
Key takeaway
Raggi-X is a leading provider of security screening systems, specializing in maintenance and service for advanced technology used in airports and secure facilities. Their commitment to high-quality solutions and experienced technicians ensures operational efficiency and reliability in security screening.
Reference
Core business
Company – Raggi-X
Decell Technologies Ltd.
Israelândia, Brazil
C
11-50 Employees
2000
Key takeaway
Decell Technologies Ltd. specializes in providing accurate, real-time traffic information through innovative data analysis, positioning itself as a leader in the field. Their advanced technology and strategic partnerships enhance their mission to deliver high-quality traffic data.
Reference
Product
Decell Technologies
Bionovis
Valinhos, Brazil
C
51-100 Employees
2012
Key takeaway
Bionovis is a pioneering Brazilian biopharmaceutical company focused on innovating and expanding its portfolio of complex biologics, which includes a commitment to research and development in high-quality biopharmaceuticals. With over 25 years of experience in biotechnology and immunology, Bionovis aims to improve patient lives through advanced therapies and innovative solutions.
Reference
Core business
Home - Bionovis
Empresa pioneira na produção de medicamentos biotecnológicosTemos como propósito melhorar a vida dos pacientes com o uso de alta tecnologia, inovação e ciência de ponta.Acesso àmedicamentosde alta complexidade para toda a população.InovaçãoProspecção de produtos e recursos científicos para licenciamento e transferência tecnológica de medicamentos inovadores e biossimilares. Previous Next Empresa pioneira na produção de medicamentos […]
GlucoGear
São Paulo, Brazil
C
1-10 Employees
2016
Key takeaway
The company emphasizes the transformative role of technology and data science in healthcare, focusing on patient-centered solutions that enhance treatment adherence and improve clinical outcomes. Their work in digital health and AI, particularly through GlucoGear, highlights a commitment to innovative and personalized approaches to disease management, which may be relevant to advancements in therapies like CAR-T.
Reference
Core business
Artificial Intelligence for Diabetes | GlucoGear
GlucoGear is developing an Artificial Intelligence to offer a preventive and personalized treatment for Diabetes.
Shield Company
Itaí, Brazil
C
11-50 Employees
2018
Key takeaway
The company, Shield Company, is dedicated to developing innovative technologies for disease prevention and treatment, emphasizing safety and efficacy. Their focus on health tech solutions aligns with advancements in therapies like CAR-T cell therapy.
Reference
Core business
About Us - Shield Company
We are a technological product and solution research and development Health Tech for the health market, focused on prevention and treatment. Established by a
Technologies which have been searched by others and may be interesting for you:
When exploring the CAR-T cell therapy industry in Brazil, several key factors should be taken into account. First, it is essential to understand the regulatory landscape, as the Brazilian Health Regulatory Agency (ANVISA) oversees the approval and commercialization of CAR-T therapies. Navigating these regulations can be complex due to the evolving nature of gene therapies and the need for compliance with both local and international standards. The competitive landscape features a mix of established pharmaceutical companies and emerging biotech firms, each vying for market share in a growing sector. Potential investors and researchers should evaluate partnerships and collaborations that can enhance innovation and broaden access to CAR-T therapies. Additionally, Brazil presents unique challenges such as healthcare infrastructure disparities and regional variations in access to advanced treatments, which can affect patient enrollment in clinical trials. However, the country also offers significant opportunities due to its large patient population and increasing investments in biotechnology. Environmental concerns related to the production and disposal of biological materials are also pertinent, necessitating adherence to sustainable practices. Lastly, understanding the global market relevance is crucial, as Brazil is positioning itself as a key player in Latin America for CAR-T therapies, attracting both domestic and international investment to drive research and development in this transformative field.
Some interesting numbers and facts about your company results for CAR-T Cell Therapy
| Country with most fitting companies | Brazil |
| Amount of fitting manufacturers | 13 |
| Amount of suitable service providers | 6 |
| Average amount of employees | 11-50 |
| Oldest suiting company | 1996 |
| Youngest suiting company | 2019 |
Some interesting questions that has been asked about the results you have just received for CAR-T Cell Therapy
What are related technologies to CAR-T Cell Therapy?
Based on our calculations related technologies to CAR-T Cell Therapy are Biomedical (Red), Bioinformatics (Gold), Environmental Biotechnology (Grey), Agricultural Biotechnology (Green), Food Related Biotechnology (Yellow)
Which industries are mostly working on CAR-T Cell Therapy?
The most represented industries which are working in CAR-T Cell Therapy are IT, Software and Services, Biotechnology, Consulting, Healthcare, Other
How does ensun find these CAR-T Cell Therapy Companies?
ensun uses an advanced search and ranking system capable of sifting through millions of companies and hundreds of millions of products and services to identify suitable matches. This is achieved by leveraging cutting-edge technologies, including Artificial Intelligence.